Here's a thought to chew on. We spend so much time agonizing over the perfect valuation, but honestly, the real answer is that the valuation is almost entirely secondary to the *terms* of the deal. A sky-high valuation with punitive liquidation preferences or poison pills can be far worse than a more reasonable one with founder-friendly terms. Are we so fixated on the headline number that we're ov